Charles River Laboratories International opened its 60,000-sq.-ft. preclinical facility in Shanghai. The new facility is aimed at fostering growth in that emerging market by assisting global and local biopharmaceutical companies with their drug development programs. The new facility is expected to provide Good Laboratory Practice (GLP) services in the first quarter of 2009.     The China facility will provide a range of services that are compliant with regulatory agencies including: Associati...